Search Results - "Bierman, PJ"

Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia by PAVLETIC, Z. S, ARROWSMITH, E. R, KOLLATH, J. P, WEISENBURGER, D. D, KESSINGER, A, WOLFF, S. N, ARMITAGE, J. O, BISHOP, M. R, BIERMAN, P. J, GOODMAN, S. A, VOSE, J. M, TARANTOLO, S. R, STEIN, R. S, BOCIEK, G, GREER, J. P, WU, C. D

“…The objective of this study was to describe the outcome of allogeneic stem cell transplantation (alloSCT) in a series of patients with B cell chronic…”
Get full text

Prognostic Value of Cellular Proliferation and Histologic Grade in Follicular Lymphoma by Martin, Anita R., Weisenburger, Dennis D., Chan, Wing C., Ruby, Elizabeth I., Anderson, James R., Vose, Julie M., Bierman, Philip J., Bast, Martin A., Daley, Donald T., Armitage, James O.

“…The clinical usefulness of histologic grading in follicular lymphoma (FL) is controversial and is further compromised by the subjective nature and poor…”
Get full text

Phase I Trial of Iodine-131 Tositumomab With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation for Relapsed Non-Hodgkin's Lymphoma by VOSE, Julie M, BIERMAN, Philip J, ENKE, Charles, HANKINS, Jordan, BOCIEK, Gregory, LYNCH, James C, ARMITAGE, James O

“…To determine the maximum outpatient dose of iodine-131 tositumomab (up to 0.75 Gy) combined with high-dose carmustine, etoposide, cytarabine, and melphalan…”
Get full text

Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies by PAVLETIC, Z. S, JOSHI, S. S, NASRATI, K, ARMITAGE, J. O, KESSINGER, A, BISHOP, M. R, PIRRUCCELLO, S. J, TARANTOLO, S. R, KOLLATH, J, REED, E. C, BIERMAN, P. J, VOSE, J. M, WARKENTIN, P. I, GROSS, T. G

“…Forty-one patients were studied at set times after allogeneic blood stem cell transplantation (alloBSCT) for recovery of lymphocyte numbers and function. Cells…”
Get full text

Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma by Hans, Christine P, Weisenburger, Dennis D, Greiner, Timothy C, Chan, Wing C, Aoun, Patricia, Cochran, Gregory T, Pan, Zenggang, Smith, Lynette M, Lynch, James C, Bociek, Robert Gregory, Bierman, Philip J, Vose, Julie M, Armitage, James O

“…We sought to determine whether identification of poor-risk subgroups of diffuse large B-cell lymphoma (DLBCL) using immunohistochemical stains would have…”
Get full text

Syngeneic Hematopoietic Stem-Cell Transplantation for Non-Hodgkin’s Lymphoma: A Comparison With Allogeneic and Autologous Transplantation—The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation by BIERMAN, Philip J, SWEETENHAM, John W, GOLDSTONE, Anthony, LOBERIZA, Fausto R, TAGHIPOUR, Goli, LAZARUS, Hillard M, RIZZO, J. Douglas, SCHMITZ, Norbert, VAN BESIEN, Koen, VOSE, Julie M, HOROWITZ, Mary

“…To compare results of syngeneic, allogeneic, and autologous hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma (NHL). The databases of the…”
Get full text

Unrelated Donor Marrow Transplantation for B-Cell Chronic Lymphocytic Leukemia After Using Myeloablative Conditioning: Results From the Center for International Blood and Marrow Transplant Research by PAVLETIC, Steven Z, KHOURI, Issa F, RINGDEN, Olle, ROY, Vivek, BALLEN, Karen, ADKINS, Douglas R, MCCARTHY, Philip, WEISDORF, Daniel, MONTSERRAT, Emili, ANASETTI, Claudio, HAAGENSON, Michael, KING, Roberta J, BIERMAN, Philip J, BISHOP, Michael R, CARSTON, Michael, GIRALT, Sergio, MOLINA, Arturo, COPELAN, Edward A

“…To determine the role of myeloablative conditioning and unrelated donor (URD) bone marrow transplantation in the treatment of patients with advanced B-cell…”
Get full text

COMBINATION OF TGR‐1202, UBLITUXIMAB, AND BENDAMUSTINE IS SAFE AND HIGHLY ACTIVE IN PATIENTS WITH ADVANCED DLBCL AND FOLLICULAR LYMPHOMA by Lunning, M.A., Vose, J.M., Bierman, P.J., Bociek, G., Schreeder, M.T., Siddiqi, T., Blumel, S.M., Cutter, K., Pauli, E.K., Bui, D., Sportelli, P., Miskin, H.P., Purdom, M., Weiss, M.S., Fowler, N.H.

Get full text

A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival by Hans, Christine P., Weisenburger, Dennis D., Vose, Julie M., Hock, Lynette M., Lynch, James C., Aoun, Patricia, Greiner, Timothy C., Chan, Wing C., Bociek, Robert G., Bierman, Philip J., Armitage, James O.

“…Grade 3 follicular lymphoma (FL3) is thought to have an aggressive clinical course. On the basis of possible biologic differences, the new World Health…”
Get full text

Follicular large cleaved cell (centrocytic) lymphoma: A distinctive but unrecognized variant of follicular lymphoma by Weisenburger, D.D., El Behery, R., Laurini, J.A., Smith, L.M., Dave, B.J., Yuan, J., Fu, K., Chan, W.C., Nathwani, B.N., Bierman, P.J., Bociek, R.G., Vose, J.M., Armitage, J.O., Greiner, T.C., Aoun, P.

Get full text

Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases by HAUKE, R. J, GREINER, T. C, SMIR, B. N, VOSE, J. M, TARANTOLO, S. R, BASHIR, R. M, BIERMAN, P. J

“…Epstein-Barr virus-associated lymphoproliferative disorders have been frequently reported as a complication of solid organ and allogeneic bone marrow…”
Get full text

Hematopoietic stem cell transplantation in mantle cell lymphoma by Ganti, A. K., Bierman, P. J., Lynch, J. C., Bociek, R. G., Vose, J. M., Armitage, J. O.

“…Background: Patients with mantle cell lymphoma (MCL) have in general, lower response rates and overall survival (OS) than those with other B-cell non-Hodgkin's…”
Get full text

High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma by Bierman, P J, Vose, J M, Anderson, J R, Bishop, M R, Kessinger, A, Armitage, J O

“…This study evaluated the results of high-dose therapy followed by autologous bone marrow or peripheral-blood stem-cell transplantation for patients with…”
Get more information

The International Prognostic Factors Project score for advanced Hodgkin’s disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation by Bierman, P. J., Lynch, J. C., Bociek, R. G., Whalen, V. L., Kessinger, A., Vose, J. M., Armitage, J. O.

“…Background: The International Prognostic Factors Project on Advanced Hodgkin’s Disease developed a seven-factor prognostic score consisting of serum albumin,…”
Get full text

Hodgkin’s Disease in the Elderly: Improved Treatment Outcome With a Doxorubicin-Containing Regimen by Weekes, C. D.

Get full text

Prognostic factors of chronic graft‐versus‐host disease after allogeneic blood stem‐cell transplantation by Pavletic, Steven Z., Smith, Lynette M., Bishop, Michael R., Lynch, James C., Tarantolo, Stefano R., Vose, Julie M., Bierman, Philip J., Hadi, Abdul, Armitage, James O., Kessinger, Anne

“…Allogeneic hematopoietic stem cells in peripheral blood transplantation (alloPBSCT) or bone marrow transplantation (alloBMT) have different biological…”
Get full text

A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation by Bishop, Michael R., Tarantolo, Stefano R., Geller, Robert B., Lynch, James C., Bierman, Philip J., Pavletic, Z. Steven, Vose, Julie M., Kruse, Susan, Dix, Suzanne P., Morris, Mary E., Armitage, James O., Kessinger, Anne

“…Blood stem cell transplantation (BSCT) results in rapid hematopoietic recovery in both the allogeneic and autologous transplant settings. Because of the large…”
Get full text

Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin’s lymphoma or Hodgkin’s lymphoma by Giles, Francis J, Vose, Julie M, Do, Kim-Anh, Johnson, Marcella M, Manshouri, Taghi, Bociek, Gregory, Bierman, Philip J, O’Brien, Susan M, Kantarjian, Hagop M, Armitage, James O, Albitar, Maher

“…Vascular endothelial growth factor (VEGF), basic-fibroblast growth factor (bFGF), hepatocyte growth factor (HGF), and angiogenin are important angiogenic…”
Get full text

Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies by Darrington, D L, Vose, J M, Anderson, J R, Bierman, P J, Bishop, M R, Chan, W C, Morris, M E, Reed, E C, Sanger, W G, Tarantolo, S R

“…To analyze the risk of developing myelodysplastic syndrome (MDS) or acute myelogenous leukemia (AML) following autologous bone marrow transplantation (ABMT) or…”
Get more information

11q22.3 deletion in B-chronic lymphocytic leukemia is specifically associated with bulky lymphadenopathy and ZAP-70 expression but not reduced expression of adhesion cell surface receptor molecules by Dickinson, John D., Gilmore, Jamie, Iqbal, Javeed, Sanger, Warren, Lynch, James C., Chan, John, Bierman, Philip J., Joshi, Shantaram S.

“…The presence of chromosome abnormalities promotes tumor progression in B-chronic lymphocytic leukemia (CLL). However, the molecular pathways that are relevant…”
Get full text